Jan 25 (Reuters) - Merck (MRK.N), opens new tab is no longer in discussions to buy cancer drug developer Revolution Medicines (RVMD.O), opens new tab, the Wall Street Journal reported on Sunday. The ...
Investors are apparently taking bets on when Revolution will be acquired. A handful of pharmas could be interested as Merck backs off. Suddenly, everyone wants in on the revolution—the RAS-addicted ...
Merck MRK2.71%increase; green up pointing triangle is no longer in discussions to buy biotech Revolution Medicines RVMD-0.13%decrease; red down pointing triangle, according to people familiar with the ...
The revolutionary ideals of liberty spread across the colonies while many suffer from enslavement. Committees of Correspondence form in hundreds of Massachusetts towns linking advocates of resistance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results